EduBourseActualitésBlueGnome Announces CytoChip Oligo Solution for High-Resolution Copy Number Analysis

BlueGnome Announces CytoChip Oligo Solution for High-Resolution Copy Number Analysis

Agilent Technologies will Manufacture Arrays
CAMBRIDGE, U. K., and SANTA CLARA, Calif., Dec. 2, 2008

Following the launch of its CytoChip Focus arrays for haematological and constitutional research, BlueGnome announced today the release of its first oligo array solution for cytogenetics. The arrays will be produced by Agilent Technologies Inc. (NYSE: A), a leading manufacturer of in situ oligo arrays.

With an overall resolution of up to 35Kb, and a focus on genomic regions known to be associated with constitutional genetic disorders, the CytoChip Oligo array is ideal for cytogenetics applications where high resolution is required. The oligos on the arrays have been designed and empirically validated to deliver improved signal to noise with both high and low quality samples.

The arrays will form a part of BlueGnome’s comprehensive solution for cytogenetics, including BAC arrays, consumables packs and confirmatory FISH probes. Users of the platform will have access to BlueGnome’s leading software, BlueFuse Multi, which in a single framework provides a complete sample and experiment management infrastructure, in addition to single-click image analysis, normalization, visualization and reporting. Critically, BlueFuse Multi allows users to easily search their own BAC and oligo array data, and also online databases, to determine regions of likely polymorphism in the genome with a minimum of time consuming manual searching of online databases.

Nick Haan, CEO of BlueGnome commented, “CytoChip oligo arrays will form an important and complementary part of BlueGnome’s complete solution for the cytogenetics community. Combined with the BlueFuse Multi software, the CytoChip oligo solution will allow users to investigate samples at ultra-high resolution in a routine environment, while keeping subjective data interpretation to a minimum.”

“Agilent’s oligo microarray technology is engineered to the highest standards to deliver robust and reproducible results,” stated Yvonne Linney, Ph.D., Agilent vice president and general manager, Genomics. “We are pleased to be working with BlueGnome to deliver a new solution to the cytogenetics community.”

CytoChip Oligo arrays are for research use only.

——————————————————————————–
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 20,000 employees serve customers in more than 110 countries. Agilent had net revenue of $5.8 billion in fiscal year 2008. Information about Agilent is available on the Web at www.agilent.com.

About Agilent in Genomics

Agilent is a leading worldwide provider of microarray-based, genomics research solutions. Agilent’s end-to-end solution includes reagents for sample preparation and microarray processing; hardware for sample QC and high-throughput microarray scanning; 60-mer oligo microarrays on industry-standard 1″ x 3″ glass slides for gene expression; comparative genomic hybridization, microRNA, splice variants and chromatin immunoprecipitation applications; custom microarray design services; and industry-leading GeneSpring software products for data analysis. More information about Agilent microarrays is available at www.opengenomics.com.

About BlueGnome

BlueGnome (www.cytochip.com) is a leading provider of arrayCGH solutions for the cytogenetics community. BlueGnome’s products include arrays for rapid and robust investigation of constitutional, haematology, and single cell samples.

# # #

Contact:

Nick Haan, BlueGnome
+1 800 418 9656
[email protected]

Eric Endicott, Agilent Technologies
+1 408 553 2005
[email protected]

Pierre Perrin-Monlouis
Pierre Perrin-Monlouis
Fondateur de Rente et Patrimoine (cabinet de gestion de patrimoine), Pierre Perrin-Monlouis est un analyste et trader pour compte propre. Il vous fait profiter de son expérience en trading grâce à ses analyses financières et décrypte pour vous les actualités des marchés. Son approche globale des marchés combine à la fois l'analyse technique et l'analyse fondamentale sur l'ensemble des marchés : crypto, forex, actions et matières premières.
ARTICLES SIMILAIRES
1200
1200